Company Filing History:
1 out of 415 
1 out of 832,843 Years Active: 2017-2018
Title: Innovator Spotlight: Christine Taylor Brew
Introduction: Christine Taylor Brew is a dedicated inventor based in Pacifica, California, with a strong focus on the medical field. With two patents to her name, she has made significant contributions to cancer treatment methodologies and therapeutic peptide formulations.
Latest Patents: One of Christine's latest patents is titled "Method for predicting and evaluating responsiveness to cancer treatment with DNA-damaging chemotherapeutic agents." This innovative method encompasses strategies for early assessment of the efficacy of cancer treatments by analyzing specific protein expression levels in circulating tumor cells, both before and after the treatment. Her second patent, "Polymer conjugates of therapeutic peptides," outlines a groundbreaking approach where peptides are chemically modified through the covalent attachment of a water-soluble oligomer, enhancing their therapeutic characteristics upon administration.
Career Highlights: Throughout her career, Christine has collaborated with various firms, including Nektar Therapeutics, a notable biotech company focused on creating innovative drug delivery systems. Her extensive research and development efforts aim to improve patient outcomes in cancer therapy.
Collaborations: Christine has had the opportunity to work alongside distinguished professionals such as Dennis G. Fry and Ute Hoch, furthering her impactful research endeavors. These collaborations have facilitated the exchange of ideas and knowledge, contributing to the advancement of her inventions.
Conclusion: Christine Taylor Brew exemplifies the spirit of innovation in the field of medical science. Her patents reflect a commitment to enhancing cancer treatment and improving patient care through scientific advancements. As she continues to develop her work, her contributions will undoubtedly influence the future of therapeutic strategies in oncology.